PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma

Haematologica

Volumn 91, Issue 4, 2006, Pages 467-474

  Garcia, José Francisco ^a,f   Roncador, Giovanna ^a   García, Juan Fernando ^a,f   Sáez, Ana Isabel ^b   Maestre, Lorena ^a   Lucas, Elena ^a   Montes Moreno, Santiago ^c   Victoria, Rebeca Fernandez ^d   Martínez Torrecuadrada, Jorge L ^a   Marafioti, Teresa ^e   Mason, David Y ^g   Piris, Miguel A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL XERAL CÍES   (Spain)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f MD ANDERSON CANCER CENTER   (Spain)

^g John Radcliffe Hospital ^*

Author keywords

BLIMP 1; Lymphoma; Monoclonal antibody; Plasma cell; PRDM1

Indexed keywords

INTERFERON REGULATORY FACTOR 4; MONOCLONAL ANTIBODY; PROTEIN BCL 6; PROTEIN BLIMP 1; PROTEIN PRDM1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; CLASSICAL HODGKIN LYMPHOMA; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOID CELL; LYMPHOPLASMACYTIC LYMPHOMA; MULTIPLE MYELOMA; PLASMABLASTIC LYMPHOMA; PLASMACYTOMA; PROTEIN EXPRESSION; T CELL LYMPHOMA; TISSUE MICROARRAY;

CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MICROARRAY ANALYSIS; PLASMA CELLS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 33645983641     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Turner CA, Jr., Mack DH, Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of lymphocytes into immunoglobulin-secreting cells. Cell 1994;77:297-306.
2. Messika EJ, Lu PS, Sung YJ, Yao T, Chi JT, Chien YH, et al. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J Exp Med 1998; 188:515-25.
3. Piskurich JF, Lin KI, Lin Y, Wang Y, Ting JP, Calame K. BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol 2000;1:526-32.
4. Angelin-Duclos C, Cattoretti G, Lin KI, Calame K. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J Immunol 2000;165:5462-71.
5. Lin Y, Wong K, Calame K. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 1997;276:596-9.
6. Ghosh N, Gyory I, Wright G, Wood J, Wright KL. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells. J Biol Chem 2001;276:15264-8.
7. Lin KI, Angelin-Duclos C, Kuo TC, Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol 2002;22: 4771-80.
8. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002; 17:51-62.
9. Cattoretti G, Angelin-Duclos C, Shaknovich R, Zhou H, Wang D, Alobeid B. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J Pathol 2005; 206:76-86.
10. Garcia JF, Maestre L, Lucas E, Sanchez-Verde L, Romero-Chala S, Piris MA, et al. Genetic immunization: a new monoclonal antibody for the detection of BCL-6 protein in paraffin sections. J Histochem Cytochem 2006;54:31-8.
11. Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, Ling KL, et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005;35:1681-91.
12. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001; 10:657-62.
13. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol J 2000;1:53-66.
14. Saez AI, Saez AJ, Artiga MJ, Perez-Rosado A, Camacho FI, Diez A, et al. Building an outcome predictor model for diffuse large B-cell lymphoma. Am J Pathol 2004;164:613-22.
15. Rodriguez A, Martinez N, Camacho FI,Ruiz-Ballesteros E, Algara P, Garcia JF, et al. Variability in the degree of expression of phosphorylated IκBα in chronic lymphocytic leukemia cases with nodal involvement. Clin Cancer Res 2004;10:6796-806.
16. Garcia JF, Camacho FI, Morente M, Fraga M, Montalban C, Alvaro T, et al. Hodgkin and Reed-Stemberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2003;101:681-9.
17. Camacho FI, Garcia JF, Cigudosa JC, Mollejo M, Algara P, Ruiz-Ballesteros E,et al. Aberrant Bcl6 protein expression in mantle cell lymphoma. Am J Surg Pathol 2004;28:1051-6.
18. Martinez-Delgado B, Cuadros M, Honrado E, Ruiz de la Parte A, Roncador G, Alves J, et al. Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas. Leukemia 2005;19:2254-63.
19. Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez-Guillermo A, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004;28:736-47.
20. Garcia JF, Villuendas R, Sanchez-Beato M, Sanchez-Aguilera A, Sanchez L, Prieto I, et al. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts. Am J Pathol 2002; 160:569-78.
21. Erber WN, Pinching AJ, Mason DY. Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet 1984;1:1042-6.
22. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, et al. The EnVision-++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998;51:506-11.
23. Marafioti T, Jones M, Facchetti F, Diss TC, Du MQ, Isaacson PG, et al. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 2003;102:2868-76.
24. Gellrich S, Ventura R, Jones M, Tan SY, Mason DY. Immunofluorescent and FISH analysis of skin biopsies. Am J Dermatopathol 2004;26:242-7.
25. Mason DY, Micklem K, Jones M. Double immunofluorescence labelling of routinely processed paraffin sections. J Pathol 2000;191:452-61.
26. Gyory I, Fejer G, Ghosh N, Seto E, Wright KL. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J Immunol 2003;170:3125-33.
27. Saitou M, Payer B, O'Carroll D, Ohinata Y, Surani MA. Blimp1 and the emergence of the germ line during development in the mouse. Cell Cycle 2005;4:1736-40.
28. Ohinata Y, Payer B, O'Carroll D, Ancelin K, Ono Y, Sano M, et al. Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 2005;436:207-13.
29. Hans CP, Weisenburger DD, Greiner TC, Gascoyne PxD, Delabie J, Ott G,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-82.
30. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005;5:230-42.
31. Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 2002; 99:2154-61.
32. Tedoldi S, Paterson JC, Hansmann ML, Natkunam Y, Rudiger T, Angelisova P, et al. Transmembrane adaptor molecules: a new category of lymphoid cell markers. Blood 2005;107:213-21.
33. Re D, Kuppers R, Diehl V. Molecular pathogenesis of Hodgkin's lymphoma. J Clin Oncol 2005;23:6379-86.
34. Evans HL, Polski JM, Deshpande V, Dunphy CH. CD5+ true SLL/CLL with plasmacytic differentiation and an unusual 1p36 translocation: case report and review of the literature. Leuk Lymphoma 2000;39:625-32.